We are live on ! Find out more
NFC

Northeast Financial Consultants Portfolio holdings

AUM $2.45B
1-Year Est. Return 15.14%
This Fund
S&P 500
This Quarter Est. Return
-0.3%
1 Year Est. Return
+15.14%
3 Year Est. Return
+63.77%
5 Year Est. Return
+108.46%
10 Year Est. Return
+198.58%
AUM
$981M
AUM Growth
+$6.51M
Cap. Flow
+$98.1M
Cap. Flow %
9.99%
Top 10 Hldgs %
39.62%
Holding
335
New
20
Increased
82
Reduced
51
Closed
13

Sector Composition

Rank Sector Weight
1 Financials 11.37%
2 Healthcare 10.99%
3 Energy 10.17%
4 Technology 5.49%
5 Communication Services 5.01%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
QQEW icon
301
First Trust Nasdaq-100 Select Equal Weight ETF
QQEW
$1.84B
$208K 0.02%
3,128
+5
+0.2% +$335
FRC
302
DELISTED
First Republic Bank
FRC
$207K 0.02%
2,142
PGX icon
303
Invesco Preferred ETF
PGX
$3.76B
$206K 0.02%
13,730
RDS.A
304
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$201K 0.02%
3,410
QVCGA
305
DELISTED
QVC Group Inc Series A
QVCGA
$195K 0.02%
390
-5
-1% -$2.94K
ISBC
306
DELISTED
Investors Bancorp, Inc.
ISBC
$195K 0.02%
17,150
PETS icon
307
PetMed Express
PETS
$42.3M
$180K 0.02%
10,000
VNM icon
308
VanEck Vietnam ETF
VNM
$507M
$179K 0.02%
10,976
CZR
309
DELISTED
Caesars Entertainment Corporation
CZR
$177K 0.02%
15,187
LTHM
310
DELISTED
Livent Corporation
LTHM
$163K 0.02%
24,401
-2,325
-9% -$15.6K
NAD icon
311
Nuveen Quality Municipal Income Fund
NAD
$2.75B
$157K 0.02%
10,959
-1,716
-14% -$24.6K
MYN icon
312
BlackRock MuniYield New York Quality Fund
MYN
$376M
$131K 0.01%
10,000
-664
-6% -$8.64K
MGNX icon
313
MacroGenics
MGNX
$249M
$128K 0.01%
10,000
NGNE icon
314
Neurogene
NGNE
$714M
$108K 0.01%
+1,920
New +$117K
GE icon
315
GE Aerospace
GE
$382B
$90K 0.01%
2,015
+1
+0% +$47
IMGN
316
DELISTED
Immunogen Inc
IMGN
$83K 0.01%
34,315
SPPI
317
DELISTED
Spectrum Pharmaceuticals Inc
SPPI
$83K 0.01%
10,000
BCRX icon
318
BioCryst Pharmaceuticals
BCRX
$2.64B
$57K 0.01%
20,000
OVV icon
319
Ovintiv
OVV
$17.6B
$56K 0.01%
2,426
IAG icon
320
IAMGOLD
IAG
$10.4B
$51K 0.01%
15,000
RRC icon
321
Range Resources
RRC
$9.5B
$42K ﹤0.01%
+11,000
New +$52.8K
LRMR icon
322
Larimar Therapeutics
LRMR
$448M
$17K ﹤0.01%
1,937
ELAN icon
323
Elanco Animal Health
ELAN
$11.4B
-7,173
Closed -$242K
GDX icon
324
VanEck Gold Miners ETF
GDX
$27.5B
-10,900
Closed -$279K
IHE icon
325
iShares US Pharmaceuticals ETF
IHE
$1.65B
-4,140
Closed -$208K

Similar funds

Northeast Financial Consultants's Q3 2019 Portfolio in Review

As of Q3 2019, Northeast Financial Consultants held 335 positions worth $981M, up 0.67% from $975M the previous quarter. Its ten largest holdings account for 40% of the portfolio.

Northeast Financial Consultants deployed $98.1M of net new capital in Q3 2019, opening 20 new positions and adding to 82 existing holdings. Its largest new stake was Blackstone Mortgage Trust: 799,602 shares worth $28.7M.

By sector, the portfolio is most concentrated in Financials at 11% of assets, up from 8.7% a quarter earlier, followed by Healthcare and Energy.

On the sell side, the largest reduction was Pfizer, an estimated $29.7M trimmed.

  • Northeast Financial Consultants's largest Q3 2019 buy was Blackstone Mortgage Trust: 799,602 shares worth $28.7M.
  • Northeast Financial Consultants added most to Berkshire Hathaway Class B in Q3 2019, an estimated $7.36M increase.
  • Northeast Financial Consultants's biggest Q3 2019 reduction was Pfizer, cutting an estimated $29.7M.
  • Northeast Financial Consultants fully exited Anadarko Petroleum in Q3 2019, selling an estimated $1.18M.
  • Northeast Financial Consultants's ten largest holdings make up 40% of its $981M portfolio in Q3 2019.
  • Northeast Financial Consultants opened 20 new positions and closed 13 in Q3 2019.
  • Northeast Financial Consultants's portfolio value rose 0.67% quarter-over-quarter to $981M.

Based on Northeast Financial Consultants's 13F filing for Q3 2019, filed 13 Nov 2019.